Site Name: Singapore - Rochester Park, UK - London - Brentford
Posted Date: Apr 19 2024
Market Access, Pricing and Strategic Planning Lead – Established Pharma
Preferred Locations:
Singapore, Singapore
London, UK
Mumbai, India
Are you looking for an opportunity to be a leader and catalyst for elevating the insights analytics function to enable delivery of a mission? If so, this is the role for you.
As the Market Access, Pricing and Strategic Planning Lead (MAPP) – Established Pharma: you will work with a variety of stakeholders to maximise the long-term value of GSK ‘s medicines, working in partnership with cross functional teams including commercial, medical affairs, supply and development. Specifically support long term planning related to lifecycle management of EP products, drive focus on gross to net (G2N) strategies for priority brands to maximise value and support the business development team with market access input as required.
Through data and insight, develop clear, competitive lifecycle strategies and plans, to maintain value or assess discontinuation or external partnering options in partnership with a variety of key stakeholders.
In this role you'll develop and stretch to be best in industry across key Global Strategy and Enterprise Leadership Capabilities. Within GSK's Pharmaceuticals business, as a MAPP you are expected to maintain or generate Value for GSK and ultimately improve the lives of patients around the world.
Key responsibilities:
Strategy
Execution
People
We are looking for professionals with these required skills to achieve our goals:
If you have the following characteristics, it would be a plus:
Our values and expectations are at the heart of everything we do and form an important part of our culture. These include Patient focus, Transparency, Respect, Integrity along with Courage, Accountability, Development, and Teamwork. #AheadTogether
Why GSK?
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Job posted: Apr 19, 2024
Expiration date: Apr 19, 2025